Sequenom Raises Full-Year Projections on Higher Q2 MassArray Sales | GenomeWeb
NEW YORK (GenomeWeb News) - Sequenom yesterday said second-quarter revenue jumped 41 percent as R&D spending climbed 79 percent and net loss grew 23 percent.
 
Total receipts for the three months ended June 30, 2007 rose to $10.2 million from $7.2 million year over year.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.